Drug Profile
CDK M808
Alternative Names: CKD-M808; M808Latest Information Update: 28 Dec 2021
Price :
$50
*
At a glance
- Originator Chong Kun Dang
- Class Antirheumatics
- Mechanism of Action HDAC6 protein inhibitors; Histone deacetylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 28 Dec 2021 No recent reports of development identified for preclinical development in Rheumatoid-arthritis in South Korea
- 03 Nov 2017 Preclinical trials in Rheumatoid arthritis in South Korea
- 03 Nov 2017 Pharmacodynamics data from a preclinical study in Rheumatoid arthritis presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting (ACR/ARHP-2017)